A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil), 2 FDA Approved Pulmonary Hypertension Medications

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2014 by Stanford University.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Northwestern University
Information provided by (Responsible Party):
Stanford University
ClinicalTrials.gov Identifier:
NCT01305252
First received: November 2, 2010
Last updated: May 21, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: September 2014
  Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)